Low Risk Clinical Trials

8 recruitingLast updated: June 21, 2026

There are 8 actively recruiting low risk clinical trials across 6 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Houston, Texas, United States, Dallas, Texas, United States, Durham, North Carolina, United States. Updated daily from ClinicalTrials.gov.


Low Risk Trials at a Glance

8 actively recruiting trials for low risk are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Houston, Dallas, and Durham. Lead sponsors running low risk studies include Fundación para la Investigación Biosanitaria del Principado de Asturias, Groupe Francophone des Myelodysplasies, and Ariel L ZImerman.

Browse low risk trials by phase

Treatments under study

About Low Risk Clinical Trials

Looking for clinical trials for Low Risk? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Low Risk trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Low Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients

Skin CancerManagementLow Risk
Universitaire Ziekenhuizen KU Leuven150 enrolled1 locationNCT07330323
Recruiting

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Radiofrequency AblationPapillary Thyroid CancerLow Risk
M.D. Anderson Cancer Center50 enrolled1 locationNCT07140757
Recruiting
Not Applicable

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Hematopoietic and Lymphatic System NeoplasmHematologic NeoplasmsMyeloid Malignancy+10 more
Mayo Clinic2,000 enrolled3 locationsNCT02958462
Recruiting
Phase 1Phase 2

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Low Risk Myelodysplastic Syndromes
Rigel Pharmaceuticals86 enrolled15 locationsNCT05308264
Recruiting
Phase 1

Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)

Low Risk Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies24 enrolled3 locationsNCT06670222
Recruiting

Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS

Low Risk Myelodysplastic Syndromes
Fundación para la Investigación Biosanitaria del Principado de Asturias30 enrolled1 locationNCT06614595
Recruiting

Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.

Low Risk Differentiated Thyroid Cancer
Nova Scotia Health Authority60 enrolled1 locationNCT05510934
Recruiting

Translabial Tridimensional Ultrasound Imaging of Uterine Cervical Dilatation in First Stage of Labor

Spontaneous labor in healthy, low risk, term, singelton parturients
Ariel L ZImerman100 enrolled1 locationACTRN12610000990022